Posts

[Guest Post] Enablement, Commercial Availability, and the Durability of Agro-Biotech Patents: Lessons from Inari v. Corteva

By at

Intellectual Property Challenges in the Bio-Pharmaceutical Field

By Mike Mireles at

The Evolution of U.S. Law and the Bio-Pharmaceutical Industry

By Mike Mireles at

AIPPI Congress Report 2: Second medical use heats up a Sunday morning

By at

International patent filing strategy: a bio/pharma survey

By at

Bundesgerichtshof refers human stem cell patent case to ECJ

By at

G 2/06: No EP patents for human embryo stem cells

By at

New EPO enlarged board referral

By at

Stem cell patent

By Anonymous at